Pharmaceutical sciences http://www.globalpost.com/taxonomy/term/23385/all en Reuters Health News Summary http://www.globalpost.com/dispatch/news/thomson-reuters/130105/reuters-health-news-summary <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <p>Following is a summary of current health news briefs.</p> <p>New food safety rules aim for more accountability 2013-01-04T211825Z_4_BRE9030MC_RTROPTC_0_US-FDA-FOOD-SAFETY.XML () -</p> <p>Genetically modified food labeling measure to qualify for Washington state ballot</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130105/reuters-health-news-summary" target="_blank">read more</a></p> Business Compounding Federal assistance in the United States Food and Drug Administration Health Healthcare reform in the United States Labor Medicaid Medicine Person Career Pharmaceutical sciences Pharmacology Pharmacy Presidency of Lyndon B. Johnson Quotation Social Issues Technology Thomson Reuters Sat, 05 Jan 2013 21:23:59 +0000 5731255 at http://www.globalpost.com Reuters Health News Summary http://www.globalpost.com/dispatch/news/thomson-reuters/130111/reuters-health-news-summary <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>Following is a summary of current health news briefs.</p> <p>Cancer studies often downplay chemo side effects: study</p> <p>2013-01-11T021149Z_1_BRE90A030_RTROPTC_0_US-CANCER.XML () -</p> <p>U.S. faces shortages of flu vaccine, Tamiflu treatment</p> <p>2013-01-11T013421Z_11_BRE9080WE_RTROPTC_0_US-USA-FLU.XML () -</p> <p>Judge won't block New York City circumcision law</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130111/reuters-health-news-summary" target="_blank">read more</a></p> Health Medicine Pharmaceutical sciences Technology Thomson Reuters Fri, 11 Jan 2013 05:15:34 +0000 5732986 at http://www.globalpost.com ANALYSIS-Drug industry bets on new blockbusters in 2013 http://www.globalpost.com/dispatch/news/thomson-reuters/130115/analysis-drug-industry-bets-new-blockbusters-2013 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>* R&amp;D improving as steepest part of patent cliff passes</p> <p>* Cancer, diabetes, MS, hepatitis drugs in focus in 2013</p> <p>* Big year for GSK, Roche, Lilly, Biogen, Gilead, Novo</p> <p>By Ben Hirschler and Bill Berkrot</p> <p>LONDON/NEW YORK, Jan 15 (Reuters) - Drugmakers are betting that a new wave of medicines for cancer, diabetes, heart disease, multiple sclerosis and hepatitis will shape up as tomorrow's blockbusters in the coming 12 months.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130115/analysis-drug-industry-bets-new-blockbusters-2013" target="_blank">read more</a></p> Health Labor Pharmaceutical industry Pharmaceutical sciences Pharmacology Social Issues Technology Thomson Reuters Tue, 15 Jan 2013 12:46:07 +0000 5734669 at http://www.globalpost.com UPDATE 2-AstraZeneca's new CEO removes R&D, commercial heads http://www.globalpost.com/dispatch/news/thomson-reuters/130115/update-2-astrazenecas-new-ceo-removes-rd-commercial-heads <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>* Mackay and Zook to leave UK's second-biggest drugmaker</p> <p>* New structure removes management layer to speed decisions</p> <p>* Revamp comes ahead of results on Jan. 31, strategic review (Adds analyst comments, further details)</p> <p>By Ben Hirschler</p> <p>LONDON, Jan 15 (Reuters) - AstraZeneca's new chief executive stamped his authority on the struggling drugmaker on Tuesday by removing the heads of research and commercial operations in a management revamp designed to speed decision-making.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130115/update-2-astrazenecas-new-ceo-removes-rd-commercial-heads" target="_blank">read more</a></p> AstraZeneca Pharmaceutical sciences Pharmacology Technology Thomson Reuters Tue, 15 Jan 2013 14:15:41 +0000 5734723 at http://www.globalpost.com Reuters Health News Summary http://www.globalpost.com/dispatch/news/thomson-reuters/130118/reuters-health-news-summary-0 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>Following is a summary of current health news briefs.</p> <p>China media train fire on U.S. food giants over chicken scare</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130118/reuters-health-news-summary-0" target="_blank">read more</a></p> Business Entertainment Health Hospitality Medicine Pharmaceutical sciences Thomson Reuters Fri, 18 Jan 2013 13:15:43 +0000 5736111 at http://www.globalpost.com Reuters Health News Summary http://www.globalpost.com/dispatch/news/thomson-reuters/130119/reuters-health-news-summary <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>Following is a summary of current health news briefs.</p> <p>Is driving OK with certain age-related blind spots?</p> <p>NEW YORK (Reuters Health) - Elderly people with a certain type of blind spot were less likely to see pedestrians in time to avoid hitting them in a driving simulator, according to a new study. "In the UK and parts of Europe, in order to have a license, you need to be tested for central blind spots, but in the U.S. you don't have to," lead author Matthew Bronstad told Reuters Health.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130119/reuters-health-news-summary" target="_blank">read more</a></p> Financial data vendors Medicine Pharmaceutical sciences Thomson Reuters Sat, 19 Jan 2013 05:15:03 +0000 5736498 at http://www.globalpost.com Reuters Health News Summary http://www.globalpost.com/dispatch/news/thomson-reuters/130119/reuters-health-news-summary-0 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>Following is a summary of current health news briefs.</p> <p>Is driving OK with certain age-related blind spots?</p> <p>NEW YORK (Reuters Health) - Elderly people with a certain type of blind spot were less likely to see pedestrians in time to avoid hitting them in a driving simulator, according to a new study. "In the UK and parts of Europe, in order to have a license, you need to be tested for central blind spots, but in the U.S. you don't have to," lead author Matthew Bronstad told Reuters Health.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130119/reuters-health-news-summary-0" target="_blank">read more</a></p> Financial data vendors Medicine Pharmaceutical sciences Thomson Reuters Sat, 19 Jan 2013 14:00:21 +0000 5736555 at http://www.globalpost.com FDA head and company CEOs cheer bumper haul of new drugs http://www.globalpost.com/dispatch/news/thomson-reuters/130125/fda-head-and-company-ceos-cheer-bumper-haul-new-drugs <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>* Approvals in past 2 years "cause for optimism" -FDA head</p> <p>* Scientific progress, better diagnostics help productivity</p> <p>* Pick-up follows lean period for drug industry R&amp;D labs</p> <p>By Ben Hirschler</p> <p>DAVOS, Switzerland, Jan 25 (Reuters) - Pharmaceutical industry productivity is improving as a more targeted approach to drug development yields dividends and regulators offer speedier decisions on medicines that make a real difference to patients.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130125/fda-head-and-company-ceos-cheer-bumper-haul-new-drugs" target="_blank">read more</a></p> Clinical research Pharmaceutical sciences Pharmacology Technology Thomson Reuters Fri, 25 Jan 2013 18:45:30 +0000 5739551 at http://www.globalpost.com FDA head and company CEOs cheer bumper haul of new drugs http://www.globalpost.com/dispatch/news/thomson-reuters/130125/fda-head-and-company-ceos-cheer-bumper-haul-new-drugs-0 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>* Approvals in past 2 years "cause for optimism" -FDA head</p> <p>* Scientific progress, better diagnostics help productivity</p> <p>* Pick-up follows lean period for drug industry R&amp;D labs</p> <p>By Ben Hirschler</p> <p>DAVOS, Switzerland, Jan 25 (Reuters) - Pharmaceutical industry productivity is improving as a more targeted approach to drug development yields dividends and regulators offer speedier decisions on medicines that make a real difference to patients.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130125/fda-head-and-company-ceos-cheer-bumper-haul-new-drugs-0" target="_blank">read more</a></p> Clinical research Pharmaceutical sciences Pharmacology Technology Thomson Reuters Fri, 25 Jan 2013 19:00:28 +0000 5739558 at http://www.globalpost.com Reuters Health News Summary http://www.globalpost.com/dispatch/news/thomson-reuters/130201/reuters-health-news-summary-1 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>Following is a summary of current health news briefs.</p> <p>Insight: Revived search for a TB vaccine may be about to pay off</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130201/reuters-health-news-summary-1" target="_blank">read more</a></p> Business Chemistry Entertainment Environment Health Labor Law Pharmaceutical sciences Politics Social Issues Technology Thomson Reuters Fri, 01 Feb 2013 21:16:12 +0000 5743577 at http://www.globalpost.com UPDATE 1-GSK promises to publish detailed drug trial data http://www.globalpost.com/dispatch/news/thomson-reuters/130205/update-1-gsk-promises-publish-detailed-drug-trial-data <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>* Drugmakers under fire for keeping medicine data secret</p> <p>* New move builds on previous GSK pledge to be more open</p> <p>* GSK will now publish detailed clinical study reports</p> <p>* Industry critic Ben Goldacre says GSK move "excellent"</p> <p>LONDON, Feb 5 (Reuters) - Britain's largest drugmaker GlaxoSmithKline is extending a promise to make more of its pharmaceutical research data public by publishing detailed clinical study reports as well as the results of all drug trials.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130205/update-1-gsk-promises-publish-detailed-drug-trial-data" target="_blank">read more</a></p> Clinical research Pharmaceutical sciences Research Technology Thomson Reuters Tue, 05 Feb 2013 18:46:08 +0000 5746739 at http://www.globalpost.com Reuters Health News Summary http://www.globalpost.com/dispatch/news/thomson-reuters/130206/reuters-health-news-summary-0 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>Following is a summary of current health news briefs.</p> <p>Insight: Shrinking U.S. labor unions see relief in marijuana industry</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130206/reuters-health-news-summary-0" target="_blank">read more</a></p> Business Health Labor Medicine Pharmaceutical sciences Pharmacology Social Issues Thomson Reuters Wed, 06 Feb 2013 13:16:13 +0000 5747512 at http://www.globalpost.com Buyers eye multibillion deal for Brazilian drugmaker -sources http://www.globalpost.com/dispatch/news/thomson-reuters/130207/buyers-eye-multibillion-deal-brazilian-drugmaker-sources <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>* Lazard's Brazilian arm hired to investigate sale</p> <p>* Ache ranks as market leader in prescription drugs</p> <p>* Differing views among owners mean sale uncertain</p> <p>By Ben Hirschler and Sophie Sassard</p> <p>Feb 7 (Reuters) - International drug companies are considering bidding for Ache Laboratorios Farmaceuticos, one of Brazil's biggest drugmakers, in a deal valuing it at several billion dollars, according to people involved in the process.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130207/buyers-eye-multibillion-deal-brazilian-drugmaker-sources" target="_blank">read more</a></p> Business Health Labor Pharmaceutical sciences Pharmaceuticals policy Pharmacology Social Issues Thomson Reuters Thu, 07 Feb 2013 18:45:41 +0000 5749248 at http://www.globalpost.com Automatic spending cuts would hurt Americans, White House says http://www.globalpost.com/dispatch/news/thomson-reuters/130208/blank-headline-received-7 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>WASHINGTON, Feb 8 (Reuters) - Automatic government spending cuts due to go into effect March 1 unless Congress acts to prevent them would bite deeply into programs affecting many Americans such as law enforcement, small business assistance, food safety, and tax collection, the White House said on Friday.</p> <p>The administration urged Congress to blunt the effect of the reductions, which the White House said would slash nondefense programs by 9 percent across the board and defense programs by 13 percent, the White House said.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130208/blank-headline-received-7" target="_blank">read more</a></p> Business Entertainment Environment Health Pharmaceutical sciences Politics Thomson Reuters Fri, 08 Feb 2013 17:30:06 +0000 5750346 at http://www.globalpost.com Reuters Health News Summary http://www.globalpost.com/dispatch/news/thomson-reuters/130208/reuters-health-news-summary-1 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>Following is a summary of current health news briefs.</p> <p>Insight: GSK vaccine ingredient scrutinized for narcolepsy clues</p> <p>LONDON (Reuters) - Mounting evidence of a link between GlaxoSmithKline's &lt;GSK.L&gt; Pandemrix flu shot and a spike in narcolepsy cases among children in Europe is putting one of the vaccine's key ingredients, AS03, under intense scrutiny. The ingredient is one of a class of pharmaceuticals known as adjuvants, or boosters, designed to turbo charge the potency of a vaccine and the body's immune response to it.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130208/reuters-health-news-summary-1" target="_blank">read more</a></p> Business Health Labor Law Pharmaceutical sciences Pharmacology Religion Technology Thomson Reuters Fri, 08 Feb 2013 21:15:37 +0000 5750570 at http://www.globalpost.com